Suited to the remote trial model, the new TrialConsent will support remote consenting and at-home consenting by patients and also extends informed consent to virtual studies for sites, sponsors and patients.
TrialConsent is capable of designing, collecting and managing the informed consent process when delivered at site visit or remotely at home.
Additionally, it can serve as either a standalone solution or integrate with eCOA and enhance patient engagement on the same platform.
Exclusive features of TrialConsent provide a secure password-protected login account to patients that enables them to save progress whether they are at home or at the site.
CRF Bracket Patient Engagement and eConsent product lead Jeff Lee said: “The continually increasing demand for solutions like TrialConsent underscores the accelerating demand across the life science industry for more integration of capable, reliable electronic processes for a more patient-centred approach.
“In addition to uniquely supporting remote consent in virtual trials, TrialConsent seamlessly complements CRF Bracket’s suite of patient-centric eClinical solutions, where eConsent, eCOA, patient engagement and ePRO combine to provide a total patient centric experience.”
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData
TrialConsent enables the onboarding of patients with reduced or no site visits and is supported by technology that offers patients a simple experience.
It also allows the patient to perform study requirements independently from the site.
Earlier this month, CRF Bracket and Uber Health joined forces to make clinical research more convenient for patients.